TYRA
Tyra Biosciences, Inc.
$32.57
+0.63 (+1.97%)
At close · Jul 8
Market Cap
$1.96B
Shares
59,470,381
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$119.95M
-38.7%
FY2025
Diluted EPS
-$2.01
-33.1%
FY2025
Operating Cash Flow
-$95.14M
-36.4%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| $111.43M | $102.93M | $80.08M | $62.52M | $43.01M | $20.64M | $7.2M | |
| $31.48M | $29.83M | $24.1M | $17.43M | $15.92M | $5.65M | $2.09M | |
| — | $546K | $519K | $357K | $296K | $140K | $47K | |
| $142.91M | $132.76M | $104.18M | $79.95M | $58.93M | $26.29M | $9.3M | |
| -$142.91M | -$132.76M | -$104.18M | -$79.95M | -$58.93M | -$26.29M | -$9.3M | |
| $11.81M | $12.82M | $17.7M | $10.81M | $3.6M | -$6000 | -$39K | |
| — | $0 | $0 | $0 | $2000 | $1000 | $1000 | |
| -$131.11M | -$119.95M | -$86.48M | -$69.13M | -$55.33M | -$26.29M | -$9.34M | |
| -$131.69M | -$120.32M | -$86.09M | -$68.75M | -$55.33M | — | — | |
| USD/shares | — | -$2.01 | -$1.51 | -$1.62 | -$1.32 | -$1.91 | — |
| USD/shares | — | -$2.01 | -$1.51 | -$1.62 | -$1.32 | -$1.91 | — |
| shares | — | 59.6M | 57.22M | 42.7M | 41.88M | 13.78M | 1.54M |
| shares | — | 59.6M | 57.22M | 42.7M | 41.88M | 13.78M | 1.54M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.